awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-F025FA4B-9CDC-4026-8797-B24B0EB566ED
Q33397131-F025FA4B-9CDC-4026-8797-B24B0EB566ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-F025FA4B-9CDC-4026-8797-B24B0EB566ED
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P2860
Q33397131-F025FA4B-9CDC-4026-8797-B24B0EB566ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-F025FA4B-9CDC-4026-8797-B24B0EB566ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e81644fc35b00d657b71d050e065d42f7329072
P2860
Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.